Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing
- PMID: 20808434
- PMCID: PMC2922327
- DOI: 10.1371/journal.pone.0012029
Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing
Abstract
Background: Weak intermolecular interactions such as hydrogen bonding and hydrophobic interactions are key players in stabilizing energetically-favored ligands, in an open conformational environment of protein structures. However, it is still poorly understood how the binding parameters associated with these interactions facilitate a drug-lead to recognize a specific target and improve drugs efficacy. To understand this, comprehensive analysis of hydrophobic interactions, hydrogen bonding and binding affinity have been analyzed at the interface of c-Src and c-Abl kinases and 4-amino substituted 1H-pyrazolo [3, 4-d] pyrimidine compounds.
Methodology: In-silico docking studies were performed, using Discovery Studio software modules LigandFit, CDOCKER and ZDOCK, to investigate the role of ligand binding affinity at the hydrophobic pocket of c-Src and c-Abl kinase. Hydrophobic and hydrogen bonding interactions of docked molecules were compared using LigPlot program. Furthermore, 3D-QSAR and MFA calculations were scrutinized to quantify the role of weak interactions in binding affinity and drug efficacy.
Conclusions: The in-silico method has enabled us to reveal that a multi-targeted small molecule binds with low affinity to its respective targets. But its binding affinity can be altered by integrating the conformationally favored functional groups at the active site of the ligand-target interface. Docking studies of 4-amino-substituted molecules at the bioactive cascade of the c-Src and c-Abl have concluded that 3D structural folding at the protein-ligand groove is also a hallmark for molecular recognition of multi-targeted compounds and for predicting their biological activity. The results presented here demonstrate that hydrogen bonding and optimized hydrophobic interactions both stabilize the ligands at the target site, and help alter binding affinity and drug efficacy.
Conflict of interest statement
Figures





References
-
- Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, et al. Rational design of peptide-based HIV proteinase inhibitors. Science. 1990;248:358–361. - PubMed
-
- Blundell T, Sibanda BL, Pearl L. Three-dimensional structure, specificity and catalytic mechanism of renin. Nature. 1983;304:273–275. - PubMed
-
- Joseph N. Development of Neuraminidase Inhibitors as Anti-Influenza Virus Drugs, . DRUG DEVELOPMENT RESEARCH. 1999;46:176–196.
-
- Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature. 2006;443:45–49. - PubMed
-
- Von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993;363:418–423. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources